Management of No-Reflow With Intracoronary Thrombolysis: A Case Report

医学 溶栓 血管成形术 心脏病学 特奈特普酶 心肌梗塞 血栓 无回流现象 内科学 导管室 重症监护医学 蒂米 纤溶 心力衰竭 心室颤动 急性冠脉综合征 纤溶剂 冠状动脉血栓形成 经皮冠状动脉介入治疗 介入心脏病学 梗塞 冠状动脉疾病 血流 微循环 冠状动脉血流储备 冠状动脉闭塞 冠状动脉粥样硬化 心导管术 动脉
作者
Youssef Fihri,Driss Britel,Fatima Ezahra Elktaibi,Aatif Benyass,Zouhair Lakhal
出处
期刊:Cureus [Cureus, Inc.]
卷期号:18 (3): e105951-e105951
标识
DOI:10.7759/cureus.105951
摘要

No-reflow is a recurring phenomenon during coronary angioplasty that consists of the failure to reestablish blood flow after clearing an occluded coronary artery. Several treatments have been proposed for the management of no-reflow, including intracoronary thrombolysis, which has emerged in recent years as one of the means of managing this phenomenon. We report the case of a 68-year-old female patient with a high cardiovascular risk, admitted for the management of non-ST-elevation acute coronary syndrome, who presented a no-reflow phenomenon after angioplasty of the right coronary artery. After the failure of the various means available to reopen the artery, a 30 mg dose of tenecteplase was administered intracoronary with restoration of Thrombolysis in Myocardial Infarction III flow in the angiographic control and good clinical and rhythmic evolution. Fibrinolytic agents remain an effective means in the treatment of acute coronary syndromes with ST-segment elevation. Its use in intracoronary therapy has demonstrated its benefit in restoring flow and improving microcirculation while maintaining a satisfactory safety profile. The use of these agents in the treatment of no-reflow remains an alternative to the usual treatment, such as adenosine and verapamil, and mechanical means, such as thrombo-aspiration, allowing dissolution of the thrombus and reestablishment of the flow. The management of no-reflow phenomena remains difficult, given the varied pathophysiology of this phenomenon and the therapeutic arsenal available for its management. However, intracoronary thrombolysis for the management of no-reflow remains an attractive and interesting alternative with results that remain acceptable, but which need to be approved by studies on larger samples with more details on the dose and the administration methodology.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wangzong发布了新的文献求助30
刚刚
zhou完成签到,获得积分10
刚刚
宁语完成签到,获得积分10
刚刚
liuchair完成签到,获得积分10
刚刚
李离子发布了新的文献求助10
刚刚
Koi完成签到,获得积分10
1秒前
1秒前
1秒前
糊涂的踏歌完成签到,获得积分10
1秒前
东风完成签到,获得积分10
1秒前
2秒前
沉静土豆发布了新的文献求助10
2秒前
彭于晏的应助被阳光的荠采纳,获得10
2秒前
3秒前
3秒前
今天不下雨完成签到,获得积分10
3秒前
努力努力再努力完成签到,获得积分10
4秒前
友好的芷雪完成签到,获得积分10
4秒前
高志远发布了新的文献求助10
4秒前
汉堡包的应助被酷酷柚子采纳,获得10
4秒前
4秒前
5秒前
邓巧发布了新的文献求助10
5秒前
ding的应助被李离子采纳,获得10
6秒前
wjw完成签到,获得积分10
6秒前
6秒前
科研通AI6.3的应助被美女采纳,获得10
7秒前
7秒前
bkagyin的应助被niwyg采纳,获得10
7秒前
无极微光的应助被沐子采纳,获得20
7秒前
123发布了新的文献求助10
7秒前
柏代桃发布了新的文献求助80
8秒前
8秒前
8秒前
天问发布了新的文献求助10
8秒前
酷酷学发布了新的文献求助10
8秒前
8秒前
红汤加煎蛋完成签到,获得积分10
9秒前
jack完成签到,获得积分10
9秒前
舒服的白云完成签到,获得积分20
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181014
求助须知:如何正确求助?哪些是违规求助? 9571039
关于积分的说明 21816042
捐赠科研通 7777369
什么是DOI,文献DOI怎么找? 3433378
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479385